Advances in Psychopharmacology: Novel Therapeutics and Drug Discovery

This chapter surveys the most significant recent developments in psychiatric pharmacotherapy, encompassing new molecular targets, emerging drug classes, and innovative delivery mechanisms. It critically evaluates current evidence for novel agents across anxiety, mood, psychotic, and neurodevelopmental disorders, including compounds targeting glutamate, neuroinflammatory, and neuroendocrine pathways. The chapter also discusses the challenges and opportunities in translating preclinical pharmacological findings into clinically effective treatments, and addresses evolving regulatory and methodological frameworks in psychiatric drug development.